CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reimbursement Review Reports

Updates on CADTH drug reimbursement reviews are posted to this page. Reports are  searchable and freely available to anyone to use, download, or print for non-commercial and personal use, or private research and study, provided you do not modify them, and appropriate credit is given to CADTH.

Export to CSV
Brand Name Generic Name Therapeutic Area Recommendation Type Project Status Date Submission Received Date Recommendation Issued Proyect name
Gynazole.1 Butoconazole nitrate Do not list Complete June 30, 2004 January 26, 2005 S0017
NovoMix 30 Insulin aspart/insulin aspart protamine Do not list Complete October 13, 2005 April 26, 2006 S0041
Fosavance 70/5600 Alendronate sodium / cholecalciferol List in a similar manner to other drugs in class Complete December 18, 2008 June 17, 2009 S0153
Abilify Aripiprazole Do not list Complete November 6, 2009 April 27, 2010 S0183
Abilify Aripiprazole Do not list Complete October 1, 2013 October 22, 2014 SR0354
Abilify Aripiprazole List with clinical criteria and/or conditions Complete March 29, 2011 July 18, 2011 S0226
Abilify Maintena Aripiprazole List with criteria/condition Complete January 6, 2014 December 19, 2014 SR0366-000
Abstral Fentanyl citrate Do not list Complete June 30, 2011 December 16, 2011 S0240
Aclasta Zoledronic acid List with clinical criteria and/or conditions Complete November 29, 2007 June 25, 2008 S0114
Aclasta Zoledronic acid List with clinical criteria and/or conditions Complete July 20, 2011 November 16, 2011 S0242
Actemra Tocilizumab List with criteria/condition Complete July 29, 2013 March 19, 2014 SR0343
Actemra Tocilizumab List with clinical criteria and/or conditions Complete January 30, 2012 July 19, 2012 S0267
Actemra Tocilizumab List with clinical criteria and/or conditions Complete May 27, 2010 November 17, 2010 S0201
Actemra Tocilizumab List with criteria/condition Complete March 3, 2014 February 19, 2015 SR0374-000
Actemra tocilizumab Reimburse with clinical criteria and/or conditions Complete September 25, 2017 March 27, 2018 SR0534-000
Actikerall Fluorouracil and Salicylic Acid Reimburse with clinical criteria and/or conditions Complete August 31, 2016 March 22, 2017 SR0498
Adcirca Tadalafil List with clinical criteria and/or conditions Complete February 5, 2010 July 15, 2010 S0197
Adderall XR Mixed amphetamine salts Withdrawn December 15, 2004 S0027
Adderall XR Mixed amphetamine salts Do not list Complete April 13, 2004 November 24, 2004 S0010
Adderall XR Mixed amphetamine salts Do not list Complete November 29, 2007 June 25, 2008 S0116
Adempas Riociguat List with criteria/condition Complete September 30, 2013 July 17, 2014 SR0353
Adempas Riociguat List with clinical criteria and/or conditions Complete June 25, 2015 December 17, 2015 SR0438-000
Adlyxine lixisenatide Reimburse with clinical criteria and/or conditions Complete May 29, 2017 November 23, 2017 SR0520-000
Admelog Insulin lispro Cancelled SE0543-000
Advicor Niacin/lovastatin List Complete October 18, 2005 April 26, 2006 S0042
Aermony RespiClick fluticasone propionate Reimburse with clinical criteria and/or conditions Complete October 4, 2017 December 19, 2018 SR0539-000
Zenhale (inhalation aerosol) Mometasone furoate and formoterol Do not list Complete February 16, 2011 September 28, 2011 S0225
Afinitor Everolimus Do not list Complete March 19, 2014 April 15, 2015 SR0376-000
Afinitor Everolimus Do not list Complete March 8, 2013 September 25, 2013 SR0315-000
Aimovig erenumab Reimburse with clinical criteria and/or conditions Complete May 2, 2019 July 22, 2020 SR0578-000
Ajovy fremanezumab migraine Active June 3, 2020 SR0641-000
Akynzeo netupitant / palonosetron Reimburse with clinical criteria and/or conditions Complete December 8, 2017 June 20, 2018 SR0548-000
Aldurazyme Laronidase Do not list Complete February 3, 2005 July 14, 2005 S0032
Aloxi (injection) Palonosetron hydrochloride Do not list at the submitted price Complete October 5, 2012 May 15, 2013 SR0293
Aloxi (capsule) Palonosetron Withdrawn February 6, 2015 SR0415-000
Aloxi (capsule) Palonosetron hydrochloride Do not list Complete October 5, 2012 April 24, 2013 SR0294
Altace Plus Felodipine Ramipril/felodipine extended release Do not list Complete June 22, 2006 November 15, 2006 S0067
Altace HCT Ramipril/hydrochlorothiazide Cancelled October 26, 2006 S0083
Altace HCT Ramipril/hydrochlorothiazide List Complete March 26, 2007 June 14, 2007 S0095
Alvesco Ciclesonide List Complete July 24, 2006 December 20, 2006 S0074
Amevive Alefacept Do not list Complete February 28, 2006 September 27, 2006 S0053
Amevive Alefacept Do not list Complete November 16, 2004 May 26, 2005 S0024
Vocabria and Cabenuva cabotegravir sodium cabotegravir-rilpivirine Reimburse with clinical criteria and/or conditions Complete August 19, 2019 July 22, 2020 SR0628-000
Braftovi and Mektovi encorafenib and binimetinib Advanced Melanoma Pending PC0232-000
Anoro Ellipta Umeclidinium/vilanterol List with criteria/condition Complete February 26, 2014 January 15, 2015 SR0371-000
Apidra Insulin glulisine List in a similar manner to other drugs in class Complete August 29, 2008 February 19, 2009 S0144
Apprilon Doxycycline monohydrate Do not list Complete April 27, 2012 March 27, 2013 SR0279
Aptiom Eslicarbazepine acetate List with criteria/condition Complete August 15, 2014 April 16, 2015 SR0391
Aptivus Tipranavir List with clinical criteria and/or conditions Complete December 15, 2005 May 17, 2006 S0047
Arbesda RespiClick fluticasone propionate / salmeterol xinafoate Reimburse with clinical criteria and/or conditions Complete October 4, 2017 December 19, 2018 SR0540-000
Arnuity Ellipta Fluticasone furoate List with criteria/condition Complete June 26, 2015 December 17, 2015 SR0439-000
ASMANEX Mometasone furoate List Complete November 10, 2011 May 16, 2012 SR0258
Atectura Breezhaler indacaterol /mometasone furoate Asthma maintenance (adults, children 12 or older) Reimburse with clinical criteria and/or conditions Active May 19, 2020 November 24, 2020 SR0646-000
Atripla Efavirenz, emtricitabine, tenofovir disoproxil fumarate List with clinical criteria and/or conditions Complete October 30, 2007 April 17, 2008 S0111
Aubagio Teriflunomide Do not list at the submitted price Complete August 28, 2013 June 18, 2014 SR0350
Somatuline Autogel Lanreotide acetate List in a similar manner to other drugs in class Complete February 20, 2007 July 19, 2007 S0091
Avodart Dutasteride List in a similar manner to other drugs in class Complete August 24, 2004 January 20, 2005 S0019
Axert Almotriptan List in a similar manner to other drugs in class Complete December 24, 2003 May 27, 2004 S0005
Azarga Brinzolamide and timolol maleate suspension List in a similar manner to other drugs in class Complete August 28, 2009 February 18, 2010 S0173
Azilect Rasagiline mesylate Do not list Complete September 1, 2006 March 28, 2007 S0073
Azilect Rasagiline mesylate Complete March 10, 2009 S0161
Banzel Rufinamide List with clinical criteria and/or conditions Complete September 20, 2011 March 15, 2012 S0252
Baqsimi glucagon Reimburse with clinical criteria and/or conditions Complete July 24, 2019 January 22, 2020 SR0626-000
Baraclude Entecavir List with clinical criteria and/or conditions Complete December 12, 2006 November 28, 2007 S0089
Basaglar Insulin glargine List with clinical criteria and/or conditions Complete October 5, 2015 April 14, 2016 SE0451-000
Benlysta Belimumab Do not reimburse Complete May 29, 2019 April 22, 2020 SR0616-000
Benlysta Belimumab Do not list Complete September 19, 2011 April 25, 2012 S0251
Beovu brolucizumab Reimburse with clinical criteria and/or conditions Complete September 26, 2019 May 21, 2020 SR0632-000
Biktarvy bictegravir/emtricitabine/tenofovir alafenamide Reimburse with clinical criteria and/or conditions Complete April 30, 2018 October 25, 2018 SR0567-000
Inflectra (Subsequent Entry Biologic) Infliximab Reimburse with clinical criteria and/or conditions Complete April 12, 2016 October 25, 2016 SE0483-000
Botox OnabotulinumtoxinA List with criteria/condition Complete November 25, 2013 November 12, 2014 SR0362
Botox onabotulinumtoxinA Reimburse with clinical criteria and/or conditions Complete November 2, 2018 October 17, 2019 SR0584-000
Botox OnabotulinumtoxinA Do not list Complete August 15, 2013 May 28, 2014 SR0345
Botox OnabotulinumtoxinA List with clinical criteria and/or conditions Complete January 31, 2012 July 19, 2012 SR0268
Braftovi encorafenib Metastatic colorectal cancer Pending PC0233-000
Ultibro Breezhaler Indacaterol/glycopyrronium List with criteria/condition Complete February 3, 2014 December 19, 2014 SR0369-000
Enerzair Breezhaler indacaterol glycopyrronium mometasone furoate Asthma maintenance, adults Reimburse with clinical criteria and/or conditions Active May 19, 2020 November 24, 2020 SR0645-000
Brenzys Etanercept Reimburse with clinical criteria and/or conditions Complete April 20, 2016 October 25, 2016 SE0485-000
Breo Ellipta fluticasone furoate/vilanterol Withdrawn May 2, 2018 SR0568-000
Breo Ellipta Fluticasone Furoate and Vilanterol (as trifenatate) List with clinical criteria and/or conditions Complete August 10, 2015 February 18, 2016 SR0442-000
Breo Ellipta fluticasone furoate/vilanterol Withdrawn June 28, 2017 SR0524-000
Breo Ellipta Fluticasone furoate /vilanterol List with criteria/condition Complete October 29, 2013 August 18, 2014 SR0358
Brilinta Ticagrelor Cancelled June 8, 2010 S0203
Brilinta Ticagrelor Do not list Complete June 1, 2011 December 16, 2011 S0234
Brilinta ticagrelor Reimburse with clinical criteria and/or conditions Complete February 18, 2016 August 25, 2016 SR0474-000
Brineura cerliponase alfa Reimburse with clinical criteria and/or conditions Complete July 31, 2018 May 23, 2019 SR0574-000
Brivlera Brivaracetam Reimburse with clinical criteria and/or conditions Complete April 19, 2016 January 25, 2017 SR0484-000
BuTrans Buprenorphine transdermal patch Do not list Complete May 9, 2011 September 28, 2011 S0233
BuTrans Buprenorphine transdermal patch Cancelled October 15, 2010 S0211
Byetta Exenatide Do not list Complete August 23, 2011 July 19, 2012 S0246
Bystolic Nebivolol Do not list at the submitted price Complete February 4, 2013 July 18, 2013 SR0307
Cablivi caplacizumab Acquired thrombotic thrombocytopenic purpura (aTTP) Do not reimburse Complete September 13, 2019 August 26, 2020 SR0633-000
Caduet Amlodipine besylate/ atorvastatin calcium List with clinical criteria and/or conditions Complete December 15, 2005 May 17, 2006 S0048
Campral Acamprosate calcium Complete July 22, 2008 S0143
Campral Acamprosate calcium List with clinical criteria and/or conditions Complete August 29, 2007 March 27, 2008 S0108
Cayston Aztreonam for inhalation solution List with clinical criteria and/or conditions Complete December 2, 2010 July 18, 2011 S0220
Celsentri Maraviroc Withdrawn November 2, 2007 S0113
Celsentri Maraviroc List with clinical criteria and/or conditions Complete May 7, 2008 November 12, 2008 S0136
Celsentri Maraviroc Do not list Complete December 8, 2010 July 18, 2011 S0221
Cerdelga Eliglustat Reimburse with clinical criteria and/or conditions Complete January 20, 2017 July 26, 2017 SR0511-000
Champix Varenicline tartrate List with clinical criteria and/or conditions Complete March 21, 2007 August 16, 2007 S0094
Cimzia Certolizumab pegol Do not list Complete September 3, 2009 May 27, 2010 S0175
Cimzia Certolizumab pegol List with criteria/condition Complete September 2, 2014 April 17, 2015 SR0394
Cimzia certolizumab pegol Reimburse with clinical criteria and/or conditions Complete May 13, 2019 November 20, 2019 SR0587-000
Cimzia Certolizumab pegol List with criteria/condition Complete June 23, 2014 April 17, 2015 SR0385-000
Cinqair reslizumab Reimburse with clinical criteria and/or conditions Complete October 24, 2018 March 27, 2019 SF0591-000
Cinqair Reslizumab Reimburse with clinical criteria and/or conditions Complete August 4, 2016 March 22, 2017 SR0495-000
Cipralex Escitalopram oxalate Do not list Complete June 8, 2006 January 24, 2007 S0064
Cipralex Escitalopram oxalate Withdrawn August 3, 2005 S0039
Ciprodex Ciprofloxacin hydrochloride & dexamethasone otic suspension List with clinical criteria and/or conditions Complete June 15, 2007 October 18, 2007 S0101
Ciprodex Ciprofloxacin hydrochloride and dexamethasone otic suspension Do not list Complete June 11, 2004 January 26, 2005 S0014
Combigan Ophthalmic Solution Brimonidine tartrate/timolol maleate List with clinical criteria and/or conditions Complete December 15, 2003 May 27, 2004 S0001
COMPLERA Emtricitabine/ rilpivirine/ tenofovir disoproxil fumarate List Complete October 19, 2011 April 19, 2012 S0256
Constella Linaclotide Do not list Complete December 17, 2014 September 23, 2015 SR0409-000
Contrave naltrexone hydrochloride and bupropion hydrochloride Do not reimburse Complete May 1, 2019 May 27, 2020 SR0610-000
Copaxone Glatiramer acetate Do not list Complete April 29, 2009 November 25, 2009 S0164
Cortiment Budesonide Do not reimburse Complete May 24, 2016 March 22, 2017 SR0491-000
Cosentyx Secukinumab Reimburse with clinical criteria and/or conditions Complete February 19, 2016 August 23, 2016 SR0476-000
Cosentyx Secukinumab List with criteria/condition Complete December 8, 2014 October 28, 2015 SR0407-000
Cosentyx Secukinumab Reimburse with clinical criteria and/or conditions Complete February 19, 2016 August 23, 2016 SR0475-000
Nucynta CR Tapentadol Do not list Complete February 1, 2011 September 28, 2011 S0224
Cresemba isavuconazole Reimburse with clinical criteria and/or conditions Complete November 2, 2018 May 15, 2019 SR0586-000
Crysvita burosumab Reimburse with clinical criteria and/or conditions Complete July 23, 2019 May 27, 2020 SR0602-000
Cubicin Daptomycin Do not list Complete March 6, 2008 September 24, 2008 S0127
Cuvposa glycopyrrolate Do not reimburse Complete May 31, 2019 June 24, 2020 SR0613-000
Cymbalta Duloxetine hydrochloride Do not list Complete February 8, 2008 August 14, 2008 S0125
Cymbalta Duloxetine hydrochloride List with clinical criteria and/or conditions Complete February 8, 2008 August 14, 2008 S0126
Cystadrops cysteamine Reimburse with clinical criteria and/or conditions Complete December 10, 2018 June 18, 2019 SR0595-000
Daklinza daclatasvir Reimburse with clinical criteria and/or conditions Complete January 6, 2016 May 19, 2016 SF0467-000
Daklinza Daclatasvir List with clinical criteria and/or conditions Complete February 13, 2015 September 21, 2015 SR0417-000
Daxas Roflumilast Do not list Complete November 30, 2010 July 27, 2011 S0218
Delstrigo doravirine lamuvidine tenofovir disoproxil fumarate Reimburse with clinical criteria and/or conditions Complete November 16, 2018 May 14, 2019 SR0581-000
Denavir Penciclovir Do not list Complete September 20, 2006 April 26, 2007 S0075
Descovy Emtricitabine /tenofovir alafenamide Reimburse with clinical criteria and/or conditions Complete January 29, 2016 August 24, 2016 SR0470-000
Diacomit Stiripentol List with criteria/condition Complete October 30, 2013 October 16, 2014 SR0360-000
Dificid Fidaxomicin Do not list at the submitted price Complete July 10, 2012 December 19, 2012 SR0285
Dovato dolutegravir / lamivudine Reimburse with clinical criteria and/or conditions Complete February 21, 2019 September 30, 2019 SR0601-000
Duaklir Genuair Aclidinium bromide/formoterol fumarate dihydrate List with clinical criteria and/or conditions Complete April 1, 2015 September 18, 2015 SR0423-000
Duobrii Halobetasol propionate and tazarotene Psoriasis, moderate to severe plaque Reimburse with clinical criteria and/or conditions Active January 24, 2020 October 28, 2020 SR0638-000
Duodopa Levodopa / carbidopa (Drug Plan Submission) Reimburse with clinical criteria and/or conditions Complete February 8, 2018 August 22, 2018 SR0557-000
Duodopa Levodopa / carbidopa Do not list Complete December 19, 2008 July 22, 2009 S0154
DuoTrav Travoprost and timolol maleate List with clinical criteria and/or conditions Complete March 24, 2006 August 24, 2006 S0057
Dupixent dupilumab Reimburse with clinical criteria and/or conditions Complete October 22, 2019 April 22, 2020 SR0636-000
Dupixent dupilumab Do not reimburse Complete October 27, 2017 June 27, 2018 SR0533-000
Dupixent dupilumab Asthma Received November 26, 2020 SR0667-000
Dymista Azelastine HCl and fluticasone propionate Do not list Complete December 9, 2014 June 17, 2015 SR0408-000
Dysport Therapeutic abobotulinumtoxinA Reimburse with clinical criteria and/or conditions Complete February 7, 2018 August 23, 2018 SR0556-000
Dysport Therapeutic abobotulinumtoxinA Reimburse with clinical criteria and/or conditions Complete April 24, 2017 October 24, 2017 SR0517-000
Dysport Therapeutic abobotulinumtoxinA Reimburse with clinical criteria and/or conditions Complete January 31, 2017 July 26, 2017 SR0512-000
Ebixa Memantine hydrochloride Do not list Complete December 21, 2004 November 23, 2005 S0025
Edarbi Azilsartan medoxomil Do not list at the submitted price Complete March 8, 2013 October 17, 2013 SR0317
Edarbyclor Azilsartan medoxomil + chlorthalidone Do not list Complete March 8, 2013 October 17, 2013 SR0318
Edurant Rilpivirine List Complete July 29, 2011 February 15, 2012 S0243
Effient Prasugrel Do not list Complete December 12, 2011 June 14, 2012 S0263
Effient Prasugrel hydrochloride Do not list Complete May 5, 2010 February 16, 2011 S0200
Egrifta Tesamorelin Do not reimburse Complete March 2, 2016 August 24, 2016 SR0477-000
Elaprase Idursulfase Do not list Complete July 13, 2007 December 19, 2007 S0104
Elelyso Taliglucerase alfa Do not list Complete August 15, 2014 October 28, 2015 SR0390
Eliquis Apixaban List with clinical criteria and/or conditions Complete September 25, 2012 March 20, 2013 SR0288
Eliquis Apixaban List with clinical criteria and/or conditions Complete December 20, 2011 June 14, 2012 S0264
Eliquis Apixaban List with clinical criteria and/or conditions Complete September 18, 2014 May 7, 2015 SR0397-000
Trelegy Ellipta fluticasone furoate umeclidinium vilanterol Reimburse with clinical criteria and/or conditions Complete March 1, 2018 August 23, 2018 SR0562-000
Incruse Ellipta Umeclidinium List with criteria/condition Complete March 4, 2015 September 18, 2015 SR0422-000
Emend Aprepitant List with clinical criteria and/or conditions Complete August 29, 2007 February 20, 2008 S0109
Restasis ophthalmic emulsion Cyclosporine Do not list Complete December 17, 2010 July 18, 2011 S0222
Enablex Darifenacin hydrobromide List with clinical criteria and/or conditions Complete October 1, 2008 April 16, 2009 S0147
Enablex Darifenacin hydrobromide Do not list Complete April 26, 2006 October 19, 2006 S0061
Enspryng satralizumab Neuromyelitis optica spectrum disorder Active October 22, 2020 SR0663-000
Entresto Sacubitril/valsartan List with clinical criteria and/or conditions Complete September 18, 2015 March 18, 2016 SR0447-000
Entresto sacubitril/valsartan Heart failure, NYHA Class II or III Active May 22, 2020 SR0644-000
Entyvio vedolizumab Crohn’s disease Active July 23, 2020 SR0647-000
Entyvio Vedolizumab List with clinical criteria and/or conditions Complete February 20, 2015 October 28, 2015 SR0421-000
Entyvio vedolizumab Reimburse with clinical criteria and/or conditions Complete November 21, 2019 May 19, 2020 SR0635-000
Entyvio Vedolizumab Reimburse with clinical criteria and/or conditions Complete April 27, 2016 October 31, 2016 SR0487-000
Epclusa Sofosbuvir/ velpatasvir Reimburse with clinical criteria and/or conditions Complete April 22, 2016 October 26, 2016 SR0486-000
Erelzi Etanercept Reimburse with clinical criteria and/or conditions Complete February 2, 2017 July 25, 2017 SE0513-000
Esbriet Pirfenidone Do not list Complete October 5, 2012 April 18, 2013 SR0292
Esbriet Pirfenidone List with criteria/condition Complete August 29, 2014 April 15, 2015 SR0393
Eucrisa crisaborole Do not reimburse Complete May 25, 2018 March 27, 2019 SR0570-000
Evra Norgelestromin/ethinyl estradiol Do not list Complete December 19, 2003 June 23, 2004 S0004
Exelon Patch Rivastigmine Do not list Complete December 21, 2007 July 23, 2008 S0123
Exjade Deferasirox List with clinical criteria and/or conditions Complete October 26, 2006 April 19, 2007 S0081
Eylea Aflibercept List with clinical criteria and/or conditions Complete September 16, 2014 May 7, 2015 SR0396-000
Eylea Aflibercept List with clinical criteria and/or conditions Complete October 17, 2014 May 7, 2015 SR0401-000
Eylea Aflibercept List with criteria/condition Complete November 18, 2013 October 20, 2014 SR0361-000
Eylea Aflibercept Reimburse with clinical criteria and/or conditions Complete December 14, 2015 July 27, 2016 SR0460-000
Fabrazyme Agalsidase beta Do not list Complete February 24, 2004 November 24, 2004 S0007
Fabrazyme Agalsidase beta Do not list Complete December 10, 2004 May 18, 2005 S0028
Fampyra Fampridine Do not list Complete April 16, 2012 November 28, 2012 SR0275
Fampyra Fampridine Withdrawn November 6, 2014 SR0404-000
Fasenra benralizumab Reimburse with clinical criteria and/or conditions Complete October 24, 2018 March 27, 2019 SF0592-000
Fasenra benralizumab Reimburse with clinical criteria and/or conditions Complete February 23, 2018 August 21, 2018 SR0561-000
Fentora Fentanyl buccal Do not reimburse Complete July 12, 2016 February 21, 2017 SR0494-000
Ferriprox Deferiprone List with clinical criteria and/or conditions Complete September 24, 2015 March 18, 2016 SR0448-000
Fibristal ulipristal acetate Reimburse with clinical criteria and/or conditions Complete March 28, 2019 July 24, 2019 SF0609-000
Fibristal ulipristal acetate Reimburse with clinical criteria and/or conditions Complete June 21, 2017 November 22, 2017 SF0528-000
Fibristal Ulipristal acetate List with criteria/condition Complete April 17, 2013 November 15, 2013 SR0326
Finacea Azelaic acid List Complete August 31, 2010 February 16, 2011 S0209
Firazyr Icatibant List with clinical criteria and/or conditions Complete March 4, 2014 December 19, 2014 SR0375-000
Firazyr icatibant CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer NotFiled
Forteo Teriparatide (rDNA origin) injection Do not list Complete December 18, 2008 July 22, 2009 S0152
Forteo Teriparatide (rDNA origin) injection Do not list Complete October 23, 2009 March 17, 2010 S0180
Forteo Teriparatide (rDNA origin) injection Do not list Complete June 8, 2004 December 22, 2004 S0015
Forteo Teriparatide (rDNA origin) injection Withdrawn May 29, 2006 S0065
Forteo Teriparatide (rDNA origin) injection Withdrawn June 12, 2009 S0169
Forteo Teriparatide (rDNA origin) injection Withdrawn December 18, 2008 S0157
Forxiga Dapagliflozin Do not list Complete September 4, 2015 April 27, 2016 SR0445-000
Forxiga dapagliflozin Heart failure with reduced ejection fraction Active March 31, 2020 SR0642-000
Forxiga Dapagliflozin List with clinical criteria and/or conditions Complete April 30, 2015 November 20, 2015 SR0428-000
Fosavance Alendronate sodium/cholecalciferol Do not list Complete March 27, 2006 September 27, 2006 S0059
Fosrenol Lanthanum carbonate hydrate Do not list Complete June 28, 2007 January 30, 2008 S0100
Fulphila pegfilgrastim Complete November 14, 2018 SE0588-000
Fycompa Perampanel List with criteria/condition Complete March 8, 2013 October 17, 2013 SR0316-000
Fycompa Perampanel Reimburse with clinical criteria and/or conditions Complete November 24, 2015 May 18, 2016 SR0458-000
Galafold migalastat Reimburse with clinical criteria and/or conditions Complete June 9, 2017 January 24, 2018 SR0522-000
Galexos Simeprevir List with criteria/condition Complete August 22, 2013 June 18, 2014 SR0347
Gelnique Oxybutynin Chloride Gel Do not list Complete October 25, 2011 May 24, 2012 S0260
Genotropin Somatropin List with criteria/condition Complete May 27, 2013 December 20, 2013 SR0332
Genotropin Somatropin List with criteria/condition Complete May 27, 2013 December 20, 2013 SR0333
Genotropin Somatropin List with criteria/condition Complete May 27, 2013 December 20, 2013 SR0334
Tudorza Genuair Aclidinium bromide List with criteria/condition Complete August 21, 2013 April 21, 2014 SR0346
Genvoya Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide List Complete September 24, 2015 March 18, 2016 SR0449-000
Gilenya Fingolimod List with clinical criteria and/or conditions Complete May 10, 2011 November 16, 2011 S0228
Glatect Glatiramer acetate Reimburse with clinical criteria and/or conditions Complete January 20, 2017 July 25, 2017 SE0510
Grastek Phleum pratense Do not list Complete September 30, 2013 September 24, 2014 SR0352
Grastofil Filgrastim List with clinical criteria and/or conditions Complete September 11, 2015 March 18, 2016 SE0446-000
Harvoni Ledipasvir / Sofosbuvir List with criteria/condition Complete September 15, 2014 March 18, 2015 SR0395
Harvoni ledipasvir, sofosbuvir Reimburse with clinical criteria and/or conditions Complete January 6, 2016 May 18, 2016 SF0465-000
Hemangiol Propranolol oral solution Reimburse with clinical criteria and/or conditions Complete August 25, 2016 February 21, 2017 SR0496-000
Hemangiol Propranolol Withdrawn December 23, 2014 SR0411-000
Hemlibra emicizumab Bleeding prevention, hemophilia A Active June 30, 2020 ST0651-000
Hepsera Adefovir dipivoxil List with clinical criteria and/or conditions Complete June 29, 2007 October 18, 2007 S0103
Hepsera Adefovir dipivoxil Do not list Complete April 24, 2006 November 29, 2006 S0060
Holkira Pak Ombitasvir/paritaprevir/ritonavir and dasabuvir List with clinical criteria and/or conditions Complete December 3, 2014 June 18, 2015 SR0406-000
Holkira Pak ombitasvir/paritaprevir/ritonavir and dasabuvir Reimburse with clinical criteria and/or conditions Complete January 6, 2016 May 19, 2016 SF0466-000
Humira Adalimumab List with clinical criteria and/or conditions Complete July 12, 2007 December 19, 2007 S0105
Humira Adalimumab List with clinical criteria and/or conditions Complete September 24, 2004 February 11, 2005 S0022
Humira Adalimumab List with clinical criteria and/or conditions Complete February 4, 2013 July 18, 2013 SR0308
Humira Adalimumab List with clinical criteria and/or conditions Complete November 17, 2006 June 27, 2007 S0087
Humira Adalimumab Do not list at the submitted price Complete September 25, 2015 April 15, 2016 SR0450-000
Humira Adalimumab Withdrawn December 23, 2013 SR0365
Humira Adalimumab List with clinical criteria and/or conditions Complete April 15, 2008 October 16, 2008 S0130
Humira Adalimumab List with clinical criteria and/or conditions Complete June 21, 2006 November 29, 2006 S0066
Humira Adalimumab Reimburse with clinical criteria and/or conditions Complete November 3, 2015 May 19, 2016 SR0455-000
Simponi I.V. Golimumab List with criteria/condition Complete September 12, 2013 July 17, 2014 SR0351
Stelara/Stelara I.V. ustekinumab Reimburse with clinical criteria and/or conditions Complete September 12, 2016 March 21, 2017 SR0501-000
Stelara/Stelara I.V ustekinumab Reimburse with clinical criteria and/or conditions Complete August 12, 2019 July 16, 2020 SR0627-000
Ikervis cyclosporine Withdrawn May 15, 2017 SR0518-000
Ilaris Canakinumab Do not list Complete July 7, 2010 January 26, 2011 S0204
Ilaris Canakinumab Reimburse with clinical criteria and/or conditions Complete December 23, 2015 June 17, 2016 SR0463-000
Ilumya tildrakizumab Psoriasis, moderate to severe plaque Suspended July 15, 2019 SR0624-000
Iluvien fluocinolone acetonide Withdrawn December 21, 2017 SR0549-000
Iluvien fluocinolone acetonide intravitreal implant Do not reimburse Complete April 3, 2019 September 26, 2019 SR0608-000
Imbruvica ibrutinib CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer NotFiled
Imfinzi durvalumab Extensive-stage small cell lung cancer Pending PC0234-000
Incivek Telaprevir List with clinical criteria and/or conditions Complete August 23, 2011 February 15, 2012 S0249
Incivek Telaprevir List with criteria/condition Complete February 19, 2013 June 13, 2013 SF0311
Incivek Telaprevir List with criteria/condition Complete December 21, 2012 June 13, 2013 SF0305-000
Inflectra Infliximab List with criteria/condition Complete June 17, 2014 December 19, 2014 SE0384-000
Inrebic fedratinib Myelofibrosis Active November 5, 2020 PC0205-000
Inspiolto Respimat Tiotropium / olodaterol List with criteria/condition Complete June 4, 2015 December 17, 2015 SR0436-000
Inspra Eplerenone Do not list at the submitted price Complete July 12, 2013 April 24, 2014 SR0342
Inspra Eplerenone Do not list Complete May 6, 2009 November 25, 2009 S0165
Intelence Etravirine List with clinical criteria and/or conditions Complete April 2, 2008 August 14, 2008 S0129
Intuniv XR Guanfacine hydrochloride Do not list Complete August 27, 2013 September 24, 2014 SR0349-000
Invega Paliperidone Do not list Complete November 1, 2007 May 28, 2008 S0112
Invega Sustenna Paliperidone palmitate Do not list Complete July 9, 2010 April 25, 2011 S0206
Invokamet Canagliflozin and metformin hydrochloride Reimburse with clinical criteria and/or conditions Complete March 3, 2016 August 25, 2016 SR0480-000
Invokana Canagliflozin Withdrawn June 5, 2013 SR0335
Invokana Canagliflozin List with criteria/condition Complete February 24, 2014 January 15, 2015 SR0370-000
Iressa Gefitinib Do not list Complete December 22, 2003 June 23, 2004 S0003
Isentress Raltegravir List with clinical criteria and/or conditions Complete November 29, 2007 May 14, 2008 S0115
Isentress Raltegravir Do not list Complete December 4, 2009 June 23, 2010 S0191
Izba travoprost ophthalmic solution Reimburse with clinical criteria and/or conditions Complete March 1, 2017 October 25, 2017 SR0516-000
Janumet Sitagliptin phosphate monohydrate / metformin hydrochloride List with clinical criteria and/or conditions Complete November 4, 2009 June 23, 2010 S0182
Januvia Sitagliptin phosphate Do not list Complete December 20, 2007 June 18, 2008 S0122
Januvia Sitagliptin phosphate List with clinical criteria and/or conditions Complete October 29, 2009 June 23, 2010 S0181
Jardiance Empagliflozin Reimburse with clinical criteria and/or conditions Complete April 27, 2016 October 26, 2016 SR0488-000
Jardiance Empagliflozin List with clinical criteria and/or conditions Complete April 23, 2015 October 15, 2015 SR0427-000
Jentadueto Linagliptin-metformin List with criteria/condition Complete March 8, 2013 October 17, 2013 SR0306
Jetrea Ocriplasmin List with criteria/condition Complete June 6, 2013 December 20, 2013 SR0337
Jinarc Tolvaptan Do not list Complete May 29, 2015 February 24, 2016 SR0435-000
Jorveza budesonide Eosinophilic esophagitis, adults Reimburse with clinical criteria and/or conditions Active November 8, 2019 October 28, 2020 SR0634-000
Jorveza budesonide Maintenance of Eosinophilic esophagitis in adults Active November 5, 2020 SR0666-000
Jublia efinaconazole Do not reimburse Complete August 2, 2018 May 23, 2019 SR0577-000
Juluca Dolutegravir rilpivirine Reimburse with clinical criteria and/or conditions Complete December 21, 2017 June 20, 2018 SR0551-000
Jurnista Hydromorphone hydrochloride Do not list Complete December 4, 2009 May 19, 2010 S0190
Juxtapid Lomitapide Do not list Complete July 8, 2014 April 17, 2015 SR0386-000
Kalydeco Ivacaftor List with criteria/condition Complete May 1, 2014 December 19, 2014 SR0379-000
Kalydeco Ivacaftor List with criteria/condition Complete May 8, 2015 November 19, 2015 SR0430-000
Kalydeco Ivacaftor List with criteria/condition Complete September 27, 2012 March 22, 2013 SR0291
Kanuma sebelipase alfa Reimburse with clinical criteria and/or conditions Complete November 2, 2017 September 26, 2018 SR0544-000
Kazano Alogliptin plus metformin Do not list Complete January 30, 2014 January 15, 2015 SR0367-000
Kevzara sarilumab Reimburse with clinical criteria and/or conditions Complete October 12, 2016 April 18, 2017 SR0503-000
Keytruda pembrolizumab Colorectal cancer Pending PC0235-000
Kineret anakinra Still's disease Pending SR0662-000
Kivexa Abacavir/lamivudine List in a similar manner to other drugs in class Complete July 26, 2005 December 7, 2005 S0038
Komboglyze Saxagliptin + metformin Withdrawn June 6, 2013 SR0336
Komboglyze Saxagliptin + metformin List with criteria/condition Complete August 23, 2013 June 20, 2014 SR0348
Kuvan Sapropterin dihydrochloride Reimburse with clinical criteria and/or conditions Complete February 1, 2016 October 26, 2016 SR0472-000
Kuvan Sapropterin dihydrochloride Do not list Complete July 8, 2010 January 26, 2011 S0205
Kuvan Sapropterin dihydrochloride Complete June 1, 2011 S0236
Kynmobi apomorphine hydrochloride Parkinson’s disease Active June 25, 2020 SR0650-000
Kynmobi apomorphine hydrochloride Withdrawn February 25, 2019 SR0604-000
Lancora Ivabradine Reimburse with clinical criteria and/or conditions Complete November 8, 2016 May 24, 2017 SR0506-000
Lantus Insulin glargine (rDNA origin) Complete June 9, 2009 S0166
Lantus Insulin glargine (rDNA origin) Do not list Complete March 27, 2006 October 25, 2006 S0058
Lantus Insulin glargine (rDNA origin) Do not list Complete February 11, 2005 September 28, 2005 S0033
Lapelga Pegfilgrastim Complete February 23, 2018 SE0555-000
Latuda Lurasidone Do not list Complete July 3, 2012 January 23, 2013 SR0284
Latuda Lurasidone List with criteria/condition Complete May 9, 2013 December 20, 2013 SR0331
Latuda lurasidone CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer NotFiled
Ledaga chlormethine hydrochloride T-cell lymphoma Pending PC0242-000
Lemtrada Alemtuzumab List with criteria/condition Complete November 27, 2014 June 18, 2015 SR0405-000
Lemtrada Alemtuzumab Withdrawn October 1, 2013 SR0355
Levemir Insulin detemir Do not list Complete December 19, 2005 August 2, 2006 S0049
Levemir Insulin detemir Do not list Complete March 10, 2009 August 20, 2009 S0160
Levemir Insulin detemir Withdrawn February 2, 2009 S0158
Levemir Insulin detemir Do not list Complete March 10, 2009 August 20, 2009 S0172
pdp-levETIRAcetam Levetiracetam Epilepsy Active July 17, 2020 SR0653-000
Lixiana VTE Edoxaban Reimburse with clinical criteria and/or conditions Complete September 9, 2016 May 25, 2017 SR0499-000
Lixiana NVAF Edoxaban Reimburse with clinical criteria and/or conditions Complete September 9, 2016 March 21, 2017 SR0500-000
Lodalis Colesevelam hydrochloride Do not list at the submitted price Complete April 27, 2012 December 19, 2012 SR0274
Lokelma sodium zirconium cyclosilicate Do not reimburse Complete May 17, 2019 March 25, 2020 SR0612-000
Lotemax Loteprednol etabonate Do not list Complete December 2, 2009 May 19, 2010 S0186
Lucentis Ranibizumab List with clinical criteria and/or conditions Complete July 12, 2007 March 27, 2008 S0098
Lucentis Ranibizumab injection List with clinical criteria and/or conditions Complete April 25, 2012 October 18, 2012 SR0276
Lucentis Ranibizumab List with criteria/condition Complete February 28, 2014 February 19, 2015 SR0373-000
Lucentis Ranibizumab List with clinical criteria and/or conditions Complete September 14, 2011 March 19, 2012 S0253
Luxturna voretigene neparvovec Vision loss, inherited retinal dystrophy Reimburse with clinical criteria and/or conditions Active April 23, 2020 November 12, 2020 SG0643-000
Lyrica Pregabalin Do not list Complete March 20, 2009 September 23, 2009 S0162
Lyrica Pregabalin Do not list Complete June 27, 2005 January 25, 2006 S0036
Pantoloc M Pantoprazole magnesium List in a similar manner to other drugs in class Complete March 17, 2006 July 20, 2006 S0054
Macugen Pegaptanib sodium Do not list Complete October 20, 2005 May 25, 2006 S0044
Mavenclad cladribine Reimburse with clinical criteria and/or conditions Complete December 1, 2017 October 24, 2018 SR0546-000
Maviret glecaprevir pibrentasvir Reimburse with clinical criteria and/or conditions Complete June 9, 2017 January 23, 2018 SR0523-000
Mayzent siponimod Reimburse with clinical criteria and/or conditions Complete September 26, 2019 July 21, 2020 SR0631-000
MDK-Nitisinone nitisinone Reimburse with clinical criteria and/or conditions Complete September 29, 2017 April 25, 2018 SR0538-000
Mictoryl Propiverine hydrochloride Reimburse with clinical criteria and/or conditions Complete October 14, 2016 April 19, 2017 SR0504-000
Mifegymiso Mifepristone and misoprostol Withdrawn February 12, 2016 SR0473
Mifegymiso Mifepristone and misoprostol Reimburse Complete October 7, 2016 April 18, 2017 SR0502
Monoferric Iron (III) Isomaltoside 1000 Reimburse with clinical criteria and/or conditions Complete June 26, 2019 March 25, 2020 SR0622-000
Monoprost latanoprost Reimburse with clinical criteria and/or conditions Complete October 25, 2017 April 24, 2018 SR0541-000
Movapo apomorphine hydrochloride Reimburse with clinical criteria and/or conditions Complete July 6, 2017 January 23, 2018 SR0527-000
Mozobil Plerixafor Do not list Complete January 24, 2012 September 26, 2012 SR0265
Multaq Dronedarone hydrochloride Do not list Complete September 18, 2009 May 27, 2010 S0177
Myfortic Mycophenolate sodium List in a similar manner to other drugs in class Complete March 3, 2005 July 8, 2005 S0034
Myozyme Alglucosidase List with clinical criteria and/or conditions Complete October 10, 2006 June 14, 2007 S0080
Myrbetriq Mirabegron List with criteria/condition Complete November 27, 2013 November 12, 2014 SR0363
Myrbetriq Mirabegron Withdrawn March 8, 2013 SR0319
Naglazyme Galsulfase (Drug Plan Submission) List with clinical criteria and/or conditions Complete August 20, 2015 February 19, 2016 SR0434-000
Nesina Alogliptin Do not list Complete January 30, 2014 January 15, 2015 SR0368-000
Neulasta Pegfilgrastim List with clinical criteria and/or conditions Complete March 29, 2004 October 27, 2004 S0009
Neupro Rotigotine Do not list Complete July 31, 2013 May 28, 2014 SR0344
Neupro Rotigotine List with clinical criteria and/or conditions Complete May 21, 2015 November 19, 2015 SR0432-000
Nexavar Sorafenib tablets Do not list Complete July 31, 2006 February 28, 2007 S0071
Nexplanon etonogestrel Prevention of pregnancy Reimburse with clinical criteria and/or conditions Active June 3, 2020 October 20, 2020 SR0648-000
Nitisinone nitisinone Reimburse with clinical criteria and/or conditions Complete January 25, 2018 August 23, 2018 SR0554-000
Norprolac Quinagolide hydrochloride List with clinical criteria and/or conditions Complete November 23, 2005 May 17, 2006 S0046
Norprolac Quinagolide hydrochloride Do not list Complete December 16, 2004 September 28, 2005 S0026
Nplate Romiplostim Do not list Complete September 29, 2009 May 27, 2010 S0179
Nucala mepolizumab Reimburse with clinical criteria and/or conditions Complete October 24, 2018 March 27, 2019 SF0593-000
Nucala Mepolizumab Reimburse with clinical criteria and/or conditions Complete December 18, 2015 June 16, 2016 SR0461-000
Nucynta tapentadol hydrochloride Do not reimburse Complete April 17, 2018 October 23, 2018 SR0563-000
NuvaRing Etonogestrel/ethinyl estradiol List with clinical criteria and/or conditions Complete May 5, 2006 November 29, 2006 S0062
Ocaliva Obeticholic Acid Reimburse with clinical criteria and/or conditions Complete December 22, 2016 July 25, 2017 SR0509-000
Ocrevus ocrelizumab Reimburse with clinical criteria and/or conditions Complete May 16, 2017 November 21, 2017 SR0519-000
Ocrevus ocrelizumab Reimburse with clinical criteria and/or conditions Complete October 26, 2017 April 26, 2018 SR0542-000
Odefsey emtricitabine/rilpivirine/ tenofovir alafenamide Reimburse with clinical criteria and/or conditions Complete November 24, 2016 May 25, 2017 SR0507-000
Ofev nintedanib chronic fibrosing interstitial lung diseases Active July 24, 2020 SR0654-000
Ofev Nintedanib List with clinical criteria and/or conditions Complete April 23, 2015 October 15, 2015 SR0426-000
Olmetec Olmesartan medoxomil List in a similar manner to other drugs in class Complete November 28, 2008 May 27, 2009 S0150
Olmetec Plus Olmesartan medoxomil + hydrochlorothiazide List in a similar manner to other drugs in class Complete November 28, 2008 May 27, 2009 S0151
Olumiant baricitinib Reimburse with clinical criteria and/or conditions Complete December 20, 2018 August 2, 2019 SR0597-000
Omnaris Ciclesonide nasal spray Do not list Complete May 7, 2008 November 12, 2008 S0137
Omnitrope Somatropin (rDNA origin) Complete June 12, 2009 S0167
Onbrez Indacaterol List in a similar manner Complete February 29, 2012 August 16, 2012 SR0273
Onglyza Saxagliptin List with criteria/condition Complete May 9, 2013 November 15, 2013 SR0329
Onglyza Saxagliptin Do not list Complete November 9, 2009 June 17, 2010 S0185
Onglyza Saxagliptin Withdrawn May 28, 2012 SR0280
Onpattro patisiran Reimburse with clinical criteria and/or conditions Complete January 25, 2019 July 25, 2019 SR0598-000
Onsolis Fentanyl Citrate Withdrawn May 10, 2011 S0229
Onsolis Fentanyl Citrate Do not list Complete August 22, 2011 February 15, 2012 S0248
Onstryv safinamide Do not reimburse Complete May 29, 2019 March 25, 2020 SR0617-000
Opdivo-Yervoy nivolumab-ipilimumab Malignant Pleural Mesothelioma (MPM) Active October 29, 2020 PC0229-000
Opsumit Macitentan List with clinical criteria and/or conditions Complete December 18, 2015 January 28, 2015 SR0364
Oralair Grass Pollen Allergen Extract List with criteria/condition Complete September 21, 2012 March 20, 2013 SR0290
Orencia Abatacept List with clinical criteria and/or conditions Complete October 26, 2006 June 27, 2007 S0084
Orencia Abatacept List in a similar manner Complete December 2, 2009 June 17, 2010 S0187
Orencia Abatacept List with clinical criteria and/or conditions Complete November 29, 2012 July 18, 2013 SR0299
Orencia Abatacept List with clinical criteria and/or conditions Complete August 29, 2008 April 22, 2009 S0145
Orfadin nitisinone Reimburse with clinical criteria and/or conditions Complete August 29, 2017 February 21, 2018 SR0531-000
Orilissa elagolix CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer NotFiled
Orkambi lumacaftor/ivacaftor Do not reimburse Complete January 28, 2016 October 26, 2016 SR0471-000
Orkambi lumacaftor/ivacaftor Do not reimburse Complete February 22, 2018 September 26, 2018 SR0559-000
Otezla Apremilast Do not list Complete October 8, 2014 July 22, 2015 SR0400-000
Otezla Apremilast Reimburse with clinical criteria and/or conditions Complete March 3, 2016 October 26, 2016 SR0478-000
Otezla Apremilast List with criteria/condition Complete June 8, 2015 December 17, 2015 SR0437-000
Ozanex ozenoxacin Do not reimburse Complete January 25, 2018 October 24, 2018 SR0553-000
Ozempic semaglutide Reimburse with clinical criteria and/or conditions Complete November 23, 2018 May 15, 2019 SR0594-000
Ozurdex Dexamethasone intravitreal implant Do not list Complete September 1, 2011 April 25, 2012 S0247
Ozurdex dexamethasone Do not reimburse Complete September 26, 2017 October 24, 2018 SR0535-000
Pegasys RBV Peginterferon alfa-2a and Ribavirin List in a similar manner to other drugs in class Complete May 14, 2004 October 14, 2004 S0013
Pheburane Sodium phenylbutyrate List Complete October 20, 2015 April 15, 2016 SR0452-000
Picato Ingenol mebutate Do not list Complete May 9, 2013 January 22, 2014 SR0330
Picato Ingenol mebutate Complete May 26, 2014 SF0382-000
Pifeltro doravirine Reimburse with clinical criteria and/or conditions Complete November 16, 2018 May 14, 2019 SR0582-000
Plegridy Peginterferon beta-1a List with criteria/condition Complete June 26, 2015 December 17, 2015 SR0440-000
Teveten Plus Eprosartan mesylate/ hydrochlorothiazide List in a similar manner to other drugs in class Complete July 8, 2004 December 15, 2004 S0016
Pradaxa Dabigatran etexilate List with clinical criteria and/or conditions Complete March 18, 2013 July 18, 2013 SF0320-000
Pradaxa Dabigatran etexilate Do not list Complete July 8, 2008 January 28, 2009 S0140
Pradaxa Dabigatran etexilate Cancelled May 31, 2010 S0202
Pradaxa Dabigatran etexilate List with clinical criteria and/or conditions Complete October 28, 2010 June 22, 2011 S0214
Praluent Alirocumab Reimburse with clinical criteria and/or conditions Complete January 12, 2016 July 20, 2016 SR0469-000
Praxbind Idarucizumab (Drug Plan Submission) Withdrawn May 30, 2016 SR0492-000
Prevymis letermovir Reimburse with clinical criteria and/or conditions Complete December 7, 2017 June 20, 2018 SR0545-000
Prexige Lumiracoxib Do not list Complete December 15, 2006 July 25, 2007 S0090
Prezcobix Darunavir/cobicistat List with criteria/condition Complete May 22, 2014 March 18, 2015 SR0381-000
Prezista Darunavir List with clinical criteria and/or conditions Complete August 29, 2006 February 14, 2007 S0072
Prezista Darunavir List with clinical criteria and/or conditions Complete March 27, 2009 October 14, 2009 S0163
Prezista Darunavir List with clinical criteria and/or conditions Complete December 22, 2009 June 17, 2010 S0194
Pristiq Desvenlafaxine succinate Do not list Complete March 5, 2009 September 23, 2009 S0159
Probuphine buprenorphine hydrochloride Reimburse with clinical criteria and/or conditions Complete December 21, 2017 August 22, 2018 SR0550-000
Procysbi cysteamine bitartrate Reimburse with clinical criteria and/or conditions Complete August 8, 2017 January 24, 2018 SR0526-000
Prolia Denosumab List with clinical criteria and/or conditions Complete August 26, 2010 March 30, 2011 S0208
Prolia Denosumab Reimburse with clinical criteria and/or conditions Complete October 26, 2015 May 20, 2016 SF0453-000
Prolia Denosumab (Drug Plan Submission) List with clinical criteria and/or conditions Complete March 10, 2015 September 21, 2015 SR0414-000
Quinsair Levofloxacin Reimburse with clinical criteria and/or conditions Complete May 31, 2016 November 21, 2016 SR0493-000
Radicava edaravone Reimburse with clinical criteria and/or conditions Complete July 5, 2018 March 27, 2019 SR0573-000
Ralivia Tramadol hydrochloride Do not list Complete October 29, 2007 June 25, 2008 S0110
RAPAFLO Silodosin Do not list Complete October 25, 2011 April 19, 2012 S0261
Raptiva Efalizumab List with clinical criteria and/or conditions Complete October 25, 2005 August 24, 2006 S0043
Raptiva Efalizumab Complete June 19, 2007 S0102
Rasilez Aliskiren Do not list Complete November 30, 2007 June 25, 2008 S0118
Ravicti glycerol phenylbutyrate Reimburse with clinical criteria and/or conditions Complete August 30, 2016 March 21, 2017 SR0497-000
Rebif Interferon beta-1a Do not list Complete March 8, 2013 August 15, 2013 SR0298
Reblozyl luspatercept beta-thalassemia associated anemia Received November 26, 2020 SR0669-000
Relistor Methylnaltrexone bromide Do not list Complete May 7, 2008 January 28, 2009 S0135
Relpax Eletriptan hydrobromide Do not list Complete September 21, 2004 March 23, 2005 S0021
Remicade Infliximab Do not list Complete September 29, 2008 April 22, 2009 S0146
Remodulin Treprostinil sodium List with clinical criteria and/or conditions Complete February 24, 2006 July 20, 2006 S0052
Remodulin Treprostinil sodium Do not list Complete July 14, 2004 November 17, 2004 S0011
Remsima Infliximab Withdrawn May 30, 2014 SE0383-000
Renflexis infliximab Reimburse with clinical criteria and/or conditions Complete September 5, 2017 February 20, 2018 SE0532-000
Repatha Evolocumab List with clinical criteria and/or conditions Complete June 30, 2015 February 19, 2016 SR0441-000
Repatha Evolocumab Reimburse with clinical criteria and/or conditions Complete February 17, 2017 November 22, 2017 SR0515-000
Replagal Agalsidase alfa Do not list Complete February 19, 2004 November 24, 2004 S0006
Resotran Prucalopride Do not list Complete January 30, 2012 July 19, 2012 SR0266
Spiriva Respimat Tiotropium bromide List with clinical criteria and/or conditions Complete December 23, 2014 July 16, 2015 SR0412-000
Revatio Sildenafil citrate List in a similar manner Complete September 20, 2006 February 14, 2007 S0076
Revestive teduglutide Reimburse with clinical criteria and/or conditions Complete May 29, 2019 November 19, 2019 SR0606-000
Revestive Teduglutide Reimburse with clinical criteria and/or conditions Complete November 26, 2015 July 27, 2016 SR0459-000
Revolade Eltrombopag olamine Do not list Complete April 26, 2011 October 24, 2011 S0230
Revolade eltrombopag CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer NotFiled
Revolade Eltrombopag List with criteria/condition Complete March 31, 2014 March 18, 2015 SR0377
Rexulti Brexpiprazole Reimburse with clinical criteria and/or conditions Complete February 3, 2017 November 22, 2017 SR0514-000
Reyataz Atazanavir List in a similar manner to other drugs in class Complete December 16, 2003 May 27, 2004 S0002
Rinvoq upadacitinib Reimburse with clinical criteria and/or conditions Complete July 4, 2019 February 4, 2020 SR0614-000
Rinvoq upadacitinib Psoriatic Arthritis, Adults. Pending SR0658-000
Rituxan Rituximab List with clinical criteria and/or conditions Complete June 26, 2006 February 14, 2007 S0068
Rituxan Rituximab List with clinical criteria and/or conditions Complete February 24, 2012 August 16, 2012 SR0270
Rosiver Ivermectin List with criteria/condition Complete April 30, 2015 November 19, 2015 SR0429-000
Ruzurgi amifampridine Lambert-Eaton myasthenic syndrome Active October 5, 2020 SR0660-000
Rybelsus semaglutide diabetes mellitus, type 2 Received November 26, 2020 SR0637-000
Samsca Tolvaptan Do not list Complete July 3, 2012 February 13, 2013 SR0283
Saphris Asenapine List with clinical criteria and/or conditions Complete December 12, 2011 June 14, 2012 S0262-001
Saphris Asenapine Do not list Complete December 12, 2011 June 14, 2012 S0262-000
Sativex Delta-9-tetrahydrocannabinol/cannabidiol Do not list Complete February 27, 2007 September 26, 2007 S0092
Sativex Delta-9-tetrahydrocannabinol/cannabidiol Do not list Complete August 7, 2007 February 20, 2008 S0106
Saxenda liraglutide Chronic weight management in adults Pending SR0668-000
Sebivo Telbivudine Do not list Complete December 4, 2006 September 26, 2007 S0088
Seebri Glycopyrronium bromide List with criteria/condition Complete November 30, 2012 May 15, 2013 SR0300
Segluromet ertugliflozin and metformin hydrochloride Do not reimburse Complete April 30, 2018 January 23, 2019 SR0566-000
Semglee insulin glargine Withdrawn November 14, 2018 SE0589-000
Sensipar Cinacalcet hydrochloride Do not list Complete August 20, 2004 March 23, 2005 S0018
Signifor Pasireotide diaspartate Do not list Complete February 27, 2014 February 24, 2015 SR0372-000
Siliq brodalumab Reimburse with clinical criteria and/or conditions Complete December 14, 2017 June 20, 2018 SR0547-000
Silkis Calcitriol Do not list Complete March 15, 2010 September 22, 2010 S0199
Simbrinza Brinzolamide / brimonidine List Complete November 3, 2014 June 17, 2015 SR0403-000
Simponi Golimumab List in a similar manner Complete September 3, 2009 March 17, 2010 S0195
Simponi Golimumab List in a similar manner Complete September 3, 2009 March 17, 2010 S0196
Simponi Golimumab Do not list at the submitted price Complete July 12, 2013 March 19, 2014 SR0341
Simponi Golimumab List in a similar manner Complete September 3, 2009 March 17, 2010 S0174
Sivextro Tedizolid phosphate Withdrawn January 16, 2015 SR0413-000
Skyrizi risankizumab Reimburse with clinical criteria and/or conditions Complete October 22, 2018 May 28, 2019 SR0583-000
Soliqua lixisenatide + insulin glargine Reimburse with clinical criteria and/or conditions Complete May 18, 2018 December 24, 2018 SR0564-000
Soliris Eculizumab Do not list Complete September 18, 2009 February 18, 2010 S0176
Soliris Eculizumab Complete February 9, 2015 SF0416-000
Soliris eculizumab Neuromyelitis optica spectrum disorder Reimburse with clinical criteria and/or conditions Complete February 25, 2020 August 19, 2020 SR0640-000
Soliris eculizumab Myasthenia Gravis (gMG), adults Reimburse with clinical criteria and/or conditions Active April 1, 2020 October 19, 2020 SR0605-000
Soliris Eculizumab Do not list Complete January 7, 2013 July 18, 2013 SR0304
Somavert Pegvisomant Do not list Complete January 25, 2006 August 2, 2006 S0050
Sovaldi Sofosbuvir List with criteria/condition Complete October 1, 2013 August 18, 2014 SR0356
Sovaldi sofosbuvir Reimburse with clinical criteria and/or conditions Complete January 6, 2016 May 18, 2016 SF0464-000
Spinraza nusinersen Reimburse with clinical criteria and/or conditions Complete June 28, 2017 December 22, 2017 SR0525-000
Spinraza Nusinersen Reimburse with clinical criteria and/or conditions Complete July 24, 2018 February 27, 2019 SR0576-000
Spravato esketamine hydrochloride Major depressive disorder (MDD), adults Active June 24, 2019 SR0621-000
Spriafil Posaconazole Do not list Complete May 24, 2007 January 30, 2008 S0097
Stalevo Carbidopa, levodopa and entacapone List in a similar manner Complete April 15, 2008 October 16, 2008 S0131
Steglatro ertugliflozin Do not reimburse Complete April 30, 2018 January 23, 2019 SR0565-000
Stelara Ustekinumab List with clinical criteria and/or conditions Complete January 7, 2009 June 17, 2009 S0156
Stelara Ustekinumab Do not list at the submitted price Complete October 30, 2013 October 20, 2014 SR0359-000
Strattera Atomoxetine hydrochloride Do not list Complete January 25, 2005 September 28, 2005 S0031
Strattera Atomoxetine hydrochloride Complete September 25, 2006 S0085
Strensiq Asfotase alfa List with criteria/condition Complete August 21, 2015 March 23, 2016 SR0443-000
Stribild Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir Disoproxil Fumarate List with criteria/condition Complete November 30, 2012 May 15, 2013 SR0301
Sublinox Zolpidem tartrate Do not list Complete March 7, 2013 September 25, 2013 SR0314
Sublocade buprenorphine Reimburse with clinical criteria and/or conditions Complete December 20, 2018 June 19, 2019 SR0579-000
Suboxone Buprenorphine/naloxone List with clinical criteria and/or conditions Complete March 6, 2008 September 24, 2008 S0128
Sunvepra Asunaprevir Reimburse with clinical criteria and/or conditions Complete February 13, 2015 July 20, 2016 SR0418-000
Sutent Sunitinib List with clinical criteria and/or conditions Complete July 20, 2006 March 28, 2007 S0069
Sutent Sunitinib malate Do not list Complete September 20, 2006 April 26, 2007 S0077
Symdeko tezacaftor/ivacaftor CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer NotFiled
Symtuza Darunavir/cobicistat/emtricitabine/tenofovir alafenamide Reimburse with clinical criteria and/or conditions Complete December 22, 2017 July 25, 2018 SR0552-000
Synjardy Empagliflozin and metformin Reimburse with clinical criteria and/or conditions Complete April 29, 2016 October 25, 2016 SR0489-000
Takhzyro lanadelumab Reimburse with clinical criteria and/or conditions Complete May 29, 2019 November 19, 2019 SR0618-000
Taltz ixekizumab Reimburse with clinical criteria and/or conditions Complete September 20, 2019 March 24, 2020 SR0630-000
Taltz ixekizumab Reimburse with clinical criteria and/or conditions Complete February 20, 2018 August 21, 2018 SR0558-000
Taltz Ixekizumab Reimburse with clinical criteria and/or conditions Complete March 23, 2016 October 25, 2016 SR0481-000
Tarceva Erlotinib List with clinical criteria and/or conditions Complete July 19, 2005 December 7, 2005 S0037
Targin Oxycodone / naloxone Cancelled November 30, 2010 S0219
Targin Oxycodone HCI / naloxone HCI Do not list Complete July 5, 2011 January 25, 2012 S0241
TBC Darunavir / cobicistat Withdrawn April 4, 2014 SR0378-000
TBC idecabtagene vicleucel Multiple myeloma Pending PG0240-000
TBC brexucabtagene autoleucel Mantle cell lymphoma Pending PG0219-000
TBC risdiplam Spinal muscular atrophy Received November 19, 2020 SR0661-000
TBC filgotinib Arthritis, Rheumatoid Received August 4, 2020 SR0656-000
TBC filgrastim Cancelled November 1, 2018 SE0585-000
TBC filgrastim Cancelled SE0596-000
TBC ranolazine Stable angina pectoris, adults Active August 17, 2020 SR0655-000
TBC etonogestrel Withdrawn September 26, 2019 SR0629-000
TBC infliximab Rheumatoid arthritis, Crohn’s disease, ulcerative colitis Active September 24, 2020 SR0659-000
TBC ravulizumab Paroxysmal nocturnal hemoglobinuria. Withdrawn July 4, 2019 SR0623-000
TBC halobetasol propionate and tazarotene Withdrawn February 4, 2019 SR0600-000
TBC ofatumumab Multiple Sclerosis, relapsing Active August 25, 2020 SR0657-0000
Tecfidera Dimethyl fumarate List with criteria/condition Complete February 4, 2013 September 25, 2013 SR0309
Technivie Ombitasvir/ paritaprevir/ ritonavir List with clinical criteria and/or conditions Complete September 4, 2015 March 18, 2016 SR0444-000
Tegsedi inotersen Reimburse with clinical criteria and/or conditions Complete February 22, 2019 December 18, 2019 SR0603-000
Telzir Fosamprenavir calcium List in a similar manner to other drugs in class Complete January 24, 2005 June 16, 2005 S0030
Thelin Sitaxsentan sodium Do not list Complete May 5, 2008 January 28, 2009 S0132
Thelin Sitaxsentan sodium Do not list Complete June 22, 2007 January 30, 2008 S0099
Tivicay Dolutegravir List Complete October 18, 2013 August 18, 2014 SR0357
Toctino Alitretinoin List with clinical criteria and/or conditions Complete May 6, 2011 October 24, 2011 S0232
Toviaz Fesoterodine fumarate List in a similar manner Complete April 27, 2012 October 18, 2012 SR0277
Trajenta Linagliptin List with clinical criteria and/or conditions Complete August 23, 2011 February 15, 2012 S0244
Tramacet Tramadol hydrochloride /acetaminophen Do not list Complete October 2, 2006 May 17, 2007 S0079
Translarna ataluren Cancelled SR0607-000
Trelstar Triptorelin pamoate List in a similar manner to other drugs in class Complete February 27, 2006 July 20, 2006 S0051
Tremfya guselkumab Reimburse with clinical criteria and/or conditions Complete August 25, 2017 February 21, 2018 SR0530-000
Tresiba insulin degludec Reimburse with clinical criteria and/or conditions Complete May 31, 2017 November 20, 2017 SR0521-000
Tridural Tramadol hydrochloride Do not list Complete November 29, 2007 April 17, 2008 S0117
Trintellix vortioxetine hydrobromide Reimburse with clinical criteria and/or conditions Complete May 1, 2019 February 12, 2020 SR0611-000
Trintellix Vortioxetine Withdrawn October 31, 2014 SR0402-000
Triumeq Dolutegravir / abacavir / lamivudine List with criteria/condition Complete July 31, 2014 April 17, 2015 SR0387
Trosec Trospium chloride List with clinical criteria and/or conditions Complete March 24, 2006 August 24, 2006 S0055
Trulicity Dulaglutide Reimburse with clinical criteria and/or conditions Complete December 22, 2015 June 16, 2016 SR0462-000
Truvada Emtricitabine/tenofovir disoproxil fumarate List with clinical criteria and/or conditions Complete May 29, 2006 October 25, 2006 S0063
Truvada Emtricitabine/tenofovir disoproxil fumarate List with clinical criteria and/or conditions Complete July 7, 2008 December 17, 2008 S0138
Truvada Emtricitabine/tenofovir disoproxil fumarate Reimburse with clinical criteria and/or conditions Complete March 3, 2016 August 24, 2016 SR0479-000
Twynsta Telmisartan/ Amlodipine List Complete August 23, 2011 December 16, 2011 S0245
Twynsta Telmisartan / Amlodipine Cancelled July 9, 2010 S0207
Tysabri Natalizumab List with clinical criteria and/or conditions Complete May 6, 2008 February 25, 2009 S0133
Tysabri Natalizumab Do not list Complete October 26, 2006 April 26, 2007 S0082
Uloric Febuxostat List with clinical criteria and/or conditions Complete October 27, 2010 April 25, 2011 S0213
Unituxin dinutuximab Neuroblastoma (pediatric) Received November 23, 2020 PC0222-000
Uptravi Selexipag Reimburse with clinical criteria and/or conditions Complete March 31, 2016 October 28, 2016 SR0482-000
Vantas Histrelin acetate Do not list Complete September 20, 2006 April 26, 2007 S0078
Vascepa icosapent ethyl Reimburse with clinical criteria and/or conditions Complete June 17, 2019 July 16, 2020 SR0619-000
Velphoro sucroferric oxyhydroxide Reimburse with clinical criteria and/or conditions Complete June 12, 2018 January 2, 2019 SR0571-000
Veltassa patiromer Hyperkalemia, adults (chronic kidney disease) Active October 30, 2020 SR0665-000
Vemlidy tenofovir alafenamide Reimburse with clinical criteria and/or conditions Complete September 28, 2017 March 26, 2018 SR0537-000
Verkazia cyclosporine Reimburse with clinical criteria and/or conditions Complete May 22, 2019 November 18, 2019 SR0615-000
Vesicare Solifenacin succinate List with clinical criteria and/or conditions Complete January 5, 2009 June 17, 2009 S0155
Vesicare Solifenacin succinate Do not list Complete July 24, 2006 January 24, 2007 S0070
VesiFlow Solifenacin succinate / tamsulosin hydrochloride Withdrawn April 6, 2015 SR0424-000
VFEND Voriconazole List with clinical criteria and/or conditions Complete March 24, 2006 October 25, 2006 S0056
VFEND Voriconazole List with clinical criteria and/or conditions Complete October 25, 2004 April 14, 2005 S0023
VFEND Voriconazole Withdrawn August 24, 2004 S0020
Viacoram perindopril arginine / amlodipine Reimburse with clinical criteria and/or conditions Complete May 2, 2016 October 26, 2016 SR0490-000
Viberzi eluxadoline Do not reimburse Complete February 23, 2018 August 24, 2018 SR0560-000
Victoza Liraglutide Do not list Complete November 29, 2010 September 28, 2011 S0217
Victoza Liraglutide Withdrawn October 20, 2016 SR0505-000
Victrelis Boceprevir List with criteria/condition Complete December 21, 2012 June 13, 2013 SF0303
Victrelis Boceprevir List with criteria/condition Complete February 19, 2013 June 13, 2013 SF0312
Victrelis Boceprevir List with clinical criteria and/or conditions Complete May 3, 2011 October 24, 2011 S0231
Viibryd vilazodone CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer NotFiled
Vimizim Elosulfase alfa Do not list Complete August 5, 2014 March 25, 2015 SR0389
Vimizim Elosulfase alfa Reimburse with clinical criteria and/or conditions Complete November 10, 2015 May 20, 2016 SR0456-000
Vimpat Lacosamide List with clinical criteria and/or conditions Complete October 25, 2010 April 25, 2011 S0212
Viread Tenofovir disoproxil fumarate Complete July 7, 2008 S0139
Viread Tenofovir disoproxil fumarate List with clinical criteria and/or conditions Complete October 2, 2008 March 18, 2009 S0148
Viread Tenofovir disoproxil fumarate Do not list Complete February 23, 2004 August 25, 2004 S0008
Viread Tenofovir disoproxil fumarate List with clinical criteria and/or conditions Complete August 11, 2005 March 15, 2006 S0040
Visanne Dienogest List with clinical criteria and/or conditions Complete October 18, 2011 April 19, 2012 S0255
Vitrakvi larotrectinib Solid tumours with NTRK gene fusion Received November 16, 2020 PC0221-000
Volibris Ambrisentan List with clinical criteria and/or conditions Complete July 9, 2008 December 17, 2008 S0142
Vonvendi von Willebrand Factor [recombinant] von Willebrand disease, adults, treatment and perioperative management Active April 29, 2020 ST0639-000
Vosevi sofosbuvir velpatasvir voxilaprevir Reimburse with clinical criteria and/or conditions Complete July 28, 2017 January 23, 2018 SR0529-000
VPRIV Velaglucerase alfa List with clinical criteria and/or conditions Complete October 28, 2010 April 25, 2011 S0215
Vyndaqel tafamidis Reimburse with clinical criteria and/or conditions Complete July 4, 2019 February 19, 2020 SR0625-000
Vyvanse Lisdexamfetamine dimesylate Do not list Complete July 10, 2009 December 18, 2009 S0171
Vyzulta latanoprostene bunod Reimburse with clinical criteria and/or conditions Complete November 23, 2018 July 24, 2019 SR0590-000
Xarelto Rivaroxaban List with clinical criteria and/or conditions Complete May 7, 2008 December 17, 2008 S0134
Xarelto Rivaroxaban Complete October 10, 2012 SF0295
Xarelto Rivaroxaban Complete June 24, 2011 S0239
Xarelto rivaroxaban Reimburse with clinical criteria and/or conditions Complete May 24, 2018 November 20, 2018 SR0569-000
Xarelto Rivaroxaban List with clinical criteria and/or conditions Complete March 18, 2013 July 18, 2013 SF0321-00
Xarelto Rivaroxaban List with criteria/condition Complete May 6, 2013 March 26, 2014 SR0327
Xarelto Rivaroxaban List with clinical criteria and/or conditions Complete October 21, 2011 April 19, 2012 S0257
Xarelto Rivaroxaban List with clinical criteria and/or conditions Complete February 27, 2012 August 16, 2012 SR0271
Xeljanz Tofacitinib List with criteria/condition Complete May 5, 2014 April 17, 2015 SR0380-000
Xeljanz tofacitinib Reimburse with clinical criteria and/or conditions Complete June 27, 2018 February 27, 2019 SR0572-000
Xeljanz tofacitinib Cancelled SR0575-000
Xeomin Clostridium botulinum neurotoxin type A, free from complexing proteins List in a similar manner Complete June 12, 2009 December 16, 2009 S0168
Xeomin Clostridium botulinum neurotoxin type A, free from complexing proteins List in a similar manner Complete June 12, 2009 December 16, 2009 S0192
Xeomin Clostridium botulinum neurotoxin type A, free from complexing proteins Do not list Complete June 12, 2009 December 16, 2009 S0193
Xermelo telotristat Do not reimburse Complete September 27, 2018 June 26, 2019 SR0580-000
Xgeva Denosumab (Drug Plan Submission) List with clinical criteria and/or conditions Complete July 31, 2015 February 25, 2016 SR0433-000
Xgeva Denosumab (Drug Plan Submission) List with clinical criteria and/or conditions Complete July 31, 2015 March 23, 2016 SR0433-001
XGEVA Denosumab List with clinical criteria and/or conditions Complete June 6, 2011 November 16, 2011 S0235
Xiaflex Collagenase clostridium histolyticum List with criteria/condition Complete August 30, 2012 March 27, 2013 SR0287
XigDuo dapagliflozin/metformin hydrochloride Reimburse with clinical criteria and/or conditions Complete January 7, 2016 July 20, 2016 SR0468-000
Zytram XL Tramadol hydrochloride Withdrawn November 3, 2006 S0086
Zytram XL Tramadol hydrochloride Do not list Complete March 15, 2007 September 26, 2007 S0093
Xofluza baloxavir marboxil Influenza CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer NotFiled
Xolair Omalizumab List with clinical criteria and/or conditions Complete September 22, 2014 May 7, 2015 SR0398-000
Xolair Omalizumab Cancelled April 18, 2005 S0035
Xolair Omalizumab (Drug Plan Submission) Reimburse with clinical criteria and/or conditions Complete November 18, 2015 May 18, 2016 SR0457-000
Xolair Omalizumab Do not list Complete October 13, 2005 March 7, 2006 S0045
Xultophy insulin degludec + liraglutide Reimburse with clinical criteria and/or conditions Complete January 30, 2019 October 24, 2019 SR0599-000
Xyrem Sodium oxybate Do not list Complete July 9, 2008 January 28, 2009 S0141
Xyrem Sodium oxybate Withdrawn August 29, 2007 S0107
Yasmin Drospirenone /ethinyl estradiol List Complete January 20, 2005 June 16, 2005 S0029
Zavesca Miglustat Do not list Complete May 13, 2004 November 24, 2004 S0012
Zaxine Rifaximin List with criteria/condition Complete August 5, 2014 April 16, 2015 SR0388
Zeldox Ziprasidone hydrochloride List with clinical criteria and/or conditions Complete January 10, 2008 August 14, 2008 S0124
Zenhale Mometasone/formoterol List with clinical criteria and/or conditions Complete June 6, 2012 December 19, 2012 S0281
Zepatier Elbasvir/grazoprevir Reimburse with clinical criteria and/or conditions Complete October 27, 2015 May 19, 2016 SR0454-000
Zeposia ozanimod Multiple Sclerosis, relapsing - remitting Active August 25, 2020 SR0652-000
Zinbryta Daclizumab beta Reimburse with clinical criteria and/or conditions Complete December 20, 2016 June 20, 2017 SR0508-000
Zolgensma onasemnogene abeparvovec Spinal muscular atrophy (SMA), pediatrics Active June 25, 2020 SG0649-000
Zolinza vorinostat Cutaneous T-cell lymphoma CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer NotFiled
Adcetris Brentuximab vedotin Notification to Implement Issued March 15, 2013 December 5, 2013 pCODR 10021
Giotrif Afatinib Notification to Implement Issued June 7, 2013 May 2, 2014 pCODR 10032
Xalkori Crizotinib Notification to Implement Issued February 17, 2015 July 21, 2015 pCODR 10054
Kadcyla Trastuzumab emtansine Notification to Implement Issued March 15, 2013 January 10, 2014 pCODR 10024
Zytiga Abiraterone acetate Notification to Implement Issued March 28, 2013 October 22, 2013 pCODR 10028
Votrient Pazopanib hydrochloride Notification to Implement Issued Resubmission Complete July 14, 2011 January 5, 2012 pCODR 10000
Treanda (in combination with rituximab) Bendamustine hydrochloride Withdrawn June 27, 2014 pCODR 10040
Tykerb (in combination with Letrozole) Lapatinib Notification to Implement Issued December 14, 2012 July 5, 2013 pCODR 10019
Arzerra Ofatumumab Notification to Implement Issued April 14, 2014 January 29, 2015 pCODR 10038
Revlimid Lenalidomide Notification to Implement Issued April 5, 2013 October 22, 2013 pCODR 10029
Nexavar Sorafenib Notification to Implement Issued December 19, 2014 July 16, 2015 pCODR 10049
Blincyto Blinatumomab Notification to Implement Issued August 24, 2015 April 1, 2016 pCODR 10064
Jakavi Ruxolitinib Notification to Implement Issued August 27, 2015 March 3, 2016 pCODR 10065
Lynparza (Resubmission) Olaparib Notification to Implement Issued March 17, 2017 September 20, 2017 pCODR 10103
Opdivo Nivolumab Notification to Implement Issued October 29, 2015 June 3, 2016 pCODR 10069
Keytruda Pembrolizumab Notification to Implement Issued February 20, 2019 October 3, 2019 pCODR 10177
Lenvima Lenvatinib Notification to Implement Issued February 8, 2019 July 24, 2019 pCODR 10175
Lonsurf Trifluridine-Tipiracil Notification to Implement Issued September 3, 2019 March 24, 2020 pCODR 10197
Keytruda Pembrolizumab Notification to Implement Issued September 14, 2018 May 31, 2019 pCODR 10153
Mylotarg Gemtuzumab Ozogamicin Notification to Implement Issued August 9, 2019 April 2, 2020 pCODR 10190
Imbruvica Ibrutinib Not Filed
Kisqali Ribociclib Notification to Implement Issued August 26, 2019 June 4, 2020 pCODR 10194
Unituxin Dinutuximab Notification to Implement Issued October 1, 2018 March 26, 2019 pCODR 10154
Xalkori Crizotinib Notification to Implement Issued October 30, 2018 May 23, 2019 pCODR 10151
Bosulif (RFA) Bosutinib Notification to Implement Issued April 8, 2019 pCODR RFA 0002
TBD Rituximab File-Closed Not Submitted pCODR 10180
Calquence Acalabrutinib Final Recommendation Posted April 7, 2020 November 17, 2020 pCODR 10211
Odomzo Sonidegib Under Review June 19, 2020 pCODR 10215
Revlimid Lenalidomide Notification to Implement Issued June 19, 2019 pCODR 10141
Opdivo in combination with Yervoy Nivolumab in combination with Ipilimumab Under Review June 23, 2020 pCODR 10218
Cabometyx Cabozantinib Notification to Implement Issued October 16, 2019 April 22, 2020 pCODR 10186
Rozlytrek Entrectinib Under Review January 8, 2020 pCODR 10206
Darzalex Daratumumab Notification to Implement Issued April 21, 2016 December 1, 2016 pCODR 10079
Adcetris Brentuximab vedotin Withdrawn April 5, 2016 pCODR 10086
Ninlaro Ixazomib Notification to Implement Issued December 16, 2016 June 29, 2017 pCODR 10088
Onivyde Nanoliposomal Irinotecan File-Closed Not Submitted pCODR 10096
Opdivo Nivolumab Notification to Implement Issued January 31, 2017 August 31, 2017 pCODR 10095
Vectibix Panitumumab Notification to Implement Issued September 8, 2017 March 29, 2018 pCODR 10118
Gazyva Obinutuzumab Notification to Implement Issued March 15, 2018 November 1, 2018 pCODR 10126
Opdivo Nivolumab Notification to Implement Issued May 8, 2018 November 29, 2018 pCODR 10134
Blincyto Blinatumomab Withdrawn June 29, 2018 pCODR 10143
Bosulif Bosutinib Notification to Implement Issued May 30, 2014 April 21, 2015 pCODR 10039
Adcetris Brentuximab vedotin Notification to Implement Issued March 14, 2013 August 29, 2013 pCODR 10020
Avastin (with capecitabine) Bevacizumab Notification to Implement Issued February 18, 2015 July 21, 2015 pCODR 10055
Votrient Pazopanib hydrochloride Notification to Implement Issued Original Submission Complete February 20, 2013 August 29, 2013 pCODR 10022
Velcade Bortezomib Notification to Implement Issued October 29, 2012 March 25, 2013 pCODR 10016
Treanda Bendamustine hydrochloride Notification to Implement Issued April 24, 2012 November 29, 2012 pCODR 10011
Perjeta Herceptin Combo Pack Pertuzumab Notification to Implement Issued November 2, 2012 August 1, 2013 pCODR 10018
Stivarga (CRC) Regorafenib Notification to Implement Issued March 22, 2013 November 15, 2013 pCODR 10026
Halaven Eribulin Mesylate Notification to Implement Issued February 9, 2012 August 2, 2012 pCODR 10005
Xtandi Enzalutamide Notification to Implement Issued October 2, 2014 June 22, 2015 pCODR 10044
Avastin Bevacizumab Notification to Implement Issued October 27, 2014 March 23, 2015 pCODR 10045
Vectibix Panitumumab Notification to Implement Issued April 15, 2015 December 3, 2015 pCODR 10060
Afinitor Everolimus Notification to Implement Issued May 30, 2016 December 1, 2016 pCODR 10083
Kyprolis Carfilzomib Notification to Implement Issued September 9, 2016 March 30, 2017 pCODR 10084
Imbruvica Ibrutinib Notification to Implement Issued January 29, 2016 July 19, 2016 pCODR 10073
Tafinlar & Mekinist in combo Dabrafenib & Trametinib in combo Notification to Implement Issued March 31, 2017 November 2, 2017 pCODR 10106
Zydelig Idelalisib Notification to Implement Issued April 12, 2016 September 29, 2016 pCODR 10075
Vizimpro Dacomitinib Notification to Implement Issued September 19, 2018 May 31, 2019 pCODR 10129
Tafinlar & Mekinist in combo Dabrafenib & Trametinib in combo Notification to Implement Issued September 21, 2018 May 3, 2019 pCODR 10152
Ibrance (with Faslodex) Palbociclib (with Fulvestrant) Notification to Implement Issued September 28, 2018 May 3, 2019 pCODR 10150
Lutathera Lutetium Lu 177 dotatate Notification to Implement Issued July 30, 2018 August 1, 2019 pCODR 10142
Bavencio Avelumab Notification to Implement Issued October 10, 2017 March 21, 2018 pCODR 10124
Alecensaro Alectinib Notification to Implement Issued August 18, 2017 March 29, 2018 pCODR 10114
Perjeta-Herceptin Combo Pack Pertuzumab-Trastuzumab Combo Pack Notification to Implement Issued April 9, 2018 November 29, 2018 pCODR 10127
Erbitux Cetuximab File-Closed Not Submitted pCODR 10128
Keytruda Pembrolizumab Notification to Implement Issued December 13, 2018 August 1, 2019 pCODR 10168
Ogivri Trastuzumab Withdrawn December 18, 2018 pCODR 10169
Ninlaro Ixazomib Notification to Implement Issued November 30, 2018 July 5, 2019 pCODR 10164
Idhifa Enasidenib Notification to Implement Issued April 5, 2019 October 31, 2019 pCODR 10144
Daurismo Glasdegib Under Review May 6, 2020 pCODR 10207
Zytiga (Resubmission) Abiraterone Suspended July 29, 2019 pCODR 10201
Oncaspar Pegaspargase Not Filed
Lynparza Olaparib Notification to Implement Issued April 18, 2019 December 5, 2019 pCODR 10174
Nubeqa Darolutamide Notification to Implement Issued August 27, 2019 April 22, 2020 pCODR 10196
Atriance Nelarabine File-Closed Not Submitted pCODR 10170
Adcetris Brentuximab Vedotin Notification to Implement Issued October 8, 2019 June 4, 2020 pCODR 10199
Xospata Gilteritinib Notification to Implement Issued October 28, 2019 May 20, 2020 pCODR 10202
Zejula Niraparib Notification to Implement Issued February 7, 2020 September 3, 2020 pCODR 10203
Erbitux Cetuximab Notification to Implement Issued June 10, 2013 January 10, 2014 pCODR 10031
Afinitor Everolimus Notification to Implement Issued February 27, 2012 August 30, 2012 pCODR 10007
Avastin Bevacizumab Notification to Implement Issued November 28, 2014 June 4, 2015 pCODR 10047
Xtandi Enzalutamide Notification to Implement Issued March 4, 2013 July 23, 2013 pCODR 10023
Inlyta Axitinib Notification to Implement Issued August 16, 2012 March 7, 2013 pCODR 10013
Perjeta or Perjeta-Herceptin Combo Pack Pertuzumab Notification to Implement Issued December 19, 2014 July 16, 2015 pCODR 10050
Imbruvica Ibrutinib Notification to Implement Issued August 15, 2014 March 5, 2015 pCODR 10043
Sutent Sunitinib malate Notification to Implement Issued November 7, 2011 May 3, 2012 pCODR 10004
Treanda Bendamustine hydrochloride Notification to Implement Issued April 24, 2012 February 19, 2013 pCODR 10011
Votrient Pazopanib Hydrochloride Notification to Implement Issued June 4, 2012 November 29, 2012 pCODR 10009
Stivarga (GIST) Regorafenib Notification to Implement Issued October 11, 2013 May 2, 2014 pCODR 10034
Opdivo Nivolumab Notification to Implement Issued August 13, 2015 April 1, 2016 pCODR 10063
Zykadia Ceritinib Notification to Implement Issued June 5, 2015 December 3, 2015 pCODR 10062
Blincyto Blinatumomab Notification to Implement Issued February 24, 2017 August 23, 2017 pCODR 10099
Keytruda Pembrolizumab Notification to Implement Issued July 7, 2017 January 5, 2018 pCODR 10109
Rydapt Midostaurin Notification to Implement Issued June 12, 2017 December 19, 2017 pCODR 10108
Ibrance Resubmission Palbociclib Notification to Implement Issued June 10, 2016 November 21, 2016 pCODR 10093
Zytiga Abiraterone Withdrawn February 25, 2019 pCODR 10166
Darzalex Daratumumab Notification to Implement Issued January 4, 2019 August 29, 2019 pCODR 10148
Stivarga Regorafenib Notification to Implement Issued October 12, 2017 April 18, 2018 pCODR 10119
Kisqali Ribociclib Notification to Implement Issued October 17, 2017 April 18, 2018 pCODR 10112
Inlyta (RFA) Axitinib Notification to Implement Issued April 18, 2017 pCODR RFA 0001
Lonsurf Trifluridine and Tipiracil Notification to Implement Issued November 6, 2017 July 6, 2018 pCODR 10122
Verzenio Abemaciclib Notification to Implement Issued December 3, 2018 July 5, 2019 pCODR 10161
Truxima Rituximab File-Closed Not Submitted pCODR 10184
TBD Trastuzumab File-Closed Not Submitted pCODR 10160
Tecentriq Atezolizumab Notification to Implement Issued March 4, 2019 January 30, 2020 pCODR 10156
Demylocan Decitabine Not Filed
Kadcyla Trastuzumab Emtansine Notification to Implement Issued July 2, 2019 January 22, 2020 pCODR 10182
Gazyva Obinutuzumab Notification to Implement Issued November 4, 2016 June 2, 2017 pCODR 10091
Tagrisso Osimertinib Notification to Implement Issued April 1, 2016 May 4, 2017 pCODR 10076
Opdivo Nivolumab Notification to Implement Issued February 24, 2016 September 1, 2016 pCODR 10074
Opdivo & Yervoy in combo Nivolumab & Ipilimumab in combo Notification to Implement Issued November 30, 2016 November 30, 2017 pCODR 10098
Lenvima Lenvatinib Notification to Implement Issued June 8, 2018 January 4, 2019 pCODR 10140
Folotyn Pralatrexate Notification to Implement Issued June 1, 2018 April 4, 2019 pCODR 10138
Alecensaro Alectinib Notification to Implement Issued January 15, 2018 July 25, 2018 pCODR 10125
Polivy Polatuzumab Vedotin Under Review September 29, 2020 pCODR 10227
Alunbrig Brigatinib Under Review September 30, 2020 pCODR 10230
Darzalex Daratumumab Notification to Implement Issued July 17, 2019 March 5, 2020 pCODR 10189
Tecentriq & Avastin Atezolizumab & Bevacizumab Notification to Implement Issued November 18, 2019 July 3, 2020 pCODR 10155
Rydapt Midostaurin Notification to Implement Issued August 13, 2019 April 2, 2020 pCODR 10193
Imbruvica Ibrutinib Not Filed
Keytruda Pembrolizumab Not Filed
Venclexta Venetoclax Obinutuzumab Final Recommendation Posted April 17, 2020 November 17, 2020 pCODR 10212
Afinitor Everolimus Notification to Implement Issued September 5, 2012 March 25, 2013 pCODR 10014
Erivedge Vismodegib Notification to Implement Issued June 14, 2013 January 10, 2014 pCODR 10015
Istodax Romidepsin Notification to Implement Issued December 1, 2014 May 19, 2015 pCODR 10048
Tafinlar & Mekinist in combo Dabrafenib & Trametinib in combo Notification to Implement Issued February 13, 2015 July 21, 2015 pCODR 10053
Xalkori Crizotinib Notification to Implement Issued Original Submission Complete March 26, 2012 October 4, 2012 pCODR 10008
Treanda Bendamustine hydrochloride Notification to Implement Issued April 24, 2012 November 29, 2012 pCODR 10010
Stivarga Resubmission (CRC) Regorafenib Notification to Implement Issued December 19, 2014 July 16, 2015 pCODR 10046
Zaltrap Aflibercept Notification to Implement Issued November 26, 2013 September 5, 2014 pCODR 10035
Yervoy Ipilimumab Notification to Implement Issued December 1, 2011 April 18, 2012 pCODR 10003
Sylvant Siltuximab Notification to Implement Issued January 30, 2015 June 22, 2015 pCODR 10052
Pomalyst Pomalidomide Notification to Implement Issued January 13, 2014 July 31, 2014 pCODR 10036
Yondelis Trabectedin Notification to Implement Issued December 22, 2015 August 5, 2016 pCODR 10071
Caprelsa Vandetanib Notification to Implement Issued August 15, 2016 March 30, 2017 pCODR 10090
Venclexta Venetoclax Withdrawn July 8, 2016 pCODR 10087
Keytruda Pembrolizumab Notification to Implement Issued April 16, 2015 November 16, 2015 pCODR 10058
Opdivo in combination with Yervoy Nivolumab in combination with Ipilimumab Notification to Implement Issued April 26, 2018 November 1, 2018 pCODR 10132
Erleada Apalutamide Notification to Implement Issued April 16, 2018 November 1, 2018 pCODR 10133
Imfinzi Durvalumab Notification to Implement Issued September 21, 2018 May 3, 2019 pCODR 10131
Opdivo Nivolumab Notification to Implement Issued August 27, 2018 March 7, 2019 pCODR 10147
Vitrakvi Larotrectinib Notification to Implement Issued February 25, 2019 October 31, 2019 pCODR 10159
Venclexta in combo Rituximab Venetoclax Notification to Implement Issued October 24, 2018 May 31, 2019 pCODR 10162
Lorbrena Lorlatinib Notification to Implement Issued June 11, 2019 January 30, 2020 pCODR 10183
Lartruvo Olaratumab Notification to Implement Issued October 26, 2017 April 18, 2018 pCODR 10111
Opdivo Nivolumab Notification to Implement Issued September 29, 2017 May 3, 2018 pCODR 10120
TBD Bevacizumab File Closed March 14, 2019 pCODR 10178
Keytruda Pembrolizumab Notification to Implement Issued February 8, 2019 January 3, 2020 pCODR 10176
Tecentriq Atezolizumab Notification to Implement Issued December 15, 2017 June 20, 2018 pCODR 10115
Zevalin Ibritumomab tiuxetan Not Filed
Kisqali Ribociclib with Fulvestrant Notification to Implement Issued August 26, 2019 April 22, 2020 pCODR 10195
Kyprolis (with lenalidomide) Carfilzomib (with lenalidomide) Notification to Implement Issued December 11, 2015 June 21, 2016 pCODR 10067
Cotellic Cobimetinib Notification to Implement Issued December 11, 2015 June 30, 2016 pCODR 10070
Imbruvica Ibrutinib Notification to Implement Issued April 20, 2016 November 3, 2016 pCODR 10085
Lenvima Lenvatinib Notification to Implement Issued April 18, 2016 September 20, 2016 pCODR 10080
Imbruvica Ibrutinib Pending April 21, 2016 November 3, 2016 pCODR 10082
Darzalex Daratumumab Notification to Implement Issued March 3, 2017 October 5, 2017 pCODR 10104
Zykadia (Resubmission) Ceritinib Notification to Implement Issued October 19, 2016 March 21, 2017 pCODR 10094
Keytruda Pembrolizumab Notification to Implement Issued July 24, 2017 March 2, 2018 pCODR 10117
Tecentriq & Avastin Atezolizumab & Bevacizumab Final Recommendation Posted May 21, 2020 November 17, 2020 pCODR 10217
Tecentriq Atezolizumab Withdrawn October 2, 2019 pCODR 10171
Adcetris Brentuximab Vedotin Under Review April 2, 2020 pCODR 10214
Calquence Acalabrutinib Under Review April 7, 2020 pCODR 10210
Abraxane Nab-paclitaxel Notification to Implement Issued February 14, 2014 September 23, 2014 pCODR 10037
Xalkori Crizotinib Notification to Implement Issued Original Submission Complete October 23, 2012 May 2, 2013 pCODR 10017
Trisenox Arsenic Trioxide Notification to Implement Issued August 30, 2013 February 18, 2014 pCODR 10033
Tafinlar Dabrafenib Notification to Implement Issued March 18, 2013 December 5, 2013 pCODR 10025
Jakavi Ruxolitinib Notification to Implement Issued June 25, 2012 January 14, 2013 pCODR 10012
Mekinist Trametinib Notification to Implement Issued May 6, 2013 October 22, 2013 pCODR 10030
Gazyva Obinutuzumab Notification to Implement Issued August 11, 2014 January 27, 2015 pCODR 10041
Alimta Pemetrexed Notification to Implement Issued May 31, 2013 November 19, 2013 pCODR 10027
Proleukin Aldesleukin (IL-2) Notification to Implement Issued January 30, 2015 June 22, 2015 pCODR 10051
Zelboraf Vemurafenib Notification to Implement Issued December 6, 2011 June 1, 2012 pCODR 10006
Yervoy Ipilimumab Notification to Implement Issued August 15, 2014 December 22, 2014 pCODR 10042
Ibrance Palbociclib Suspended November 11, 2015 pCODR 10068
Avastin Bevacizumab Notification to Implement Issued October 29, 2015 May 5, 2016 pCODR 10066
Zydelig Idelalisib Notification to Implement Issued April 7, 2015 August 18, 2015 pCODR 10057
Revlimid Lenalidomide Notification to Implement Issued May 4, 2015 December 3, 2015 pCODR 10061
Cyramza Ramucirumab Notification to Implement Issued April 15, 2015 October 29, 2015 pCODR 10059
Iclusig Ponatinib Notification to Implement Issued March 13, 2015 October 1, 2015 pCODR 10056
Nerlynx Neratinib Notification to Implement Issued April 18, 2019 December 5, 2019 pCODR 10172
Pomalyst Pomalidomide Notification to Implement Issued March 15, 2019 September 18, 2019 pCODR 10165
Cyramza Ramucirumab File-Closed Not Submitted pCODR 10078
Libtayo Cemiplimab Notification to Implement Issued July 9, 2019 January 22, 2020 pCODR 10187
Lonsurf Trifluridine and Tipiracil Notification to Implement Issued January 21, 2019 August 29, 2019 pCODR 10173
TBD Entrectinib Withdrawn July 29, 2019 pCODR 10157
Keytruda Pembrolizumab Notification to Implement Issued August 2, 2019 April 2, 2020 pCODR 10185
Erleada Apalutamide Notification to Implement Issued October 15, 2019 April 22, 2020 pCODR 10200
Blincyto Blinatumomab Notification to Implement Issued January 20, 2020 October 29, 2020 pCODR 10204
Xtandi Enzalutamide Notification to Implement Issued February 24, 2020 September 23, 2020 pCODR 10209
Keytruda Pembrolizumab Under Review May 1, 2020 pCODR 10216
Keytruda Pembrolizumab Not Filed
Adcetris Brentuximab Vedotin Under Review March 30, 2020 pCODR 10213
Lynparza Olaparib Not Filed
Sarclisa Isatuximab Under Review August 17, 2020 pCODR 10220
Zejula Niraparib Under Review September 21, 2020 pCODR 10224
Lynparza Olaparib Under Review September 22, 2020 pCODR 10223
Inqovi Decitabine-Cedazuridine Under Review October 9, 2020 pCODR 10228
Tafinlar and Mekinist Dabrafenib and Trametinib Under Review October 1, 2020 pCODR 10226
Alecensaro Alectinib Notification to Implement Issued October 3, 2016 May 4, 2017 pCODR 10092
Blincyto (Resubmission) Blinatumomab Notification to Implement Issued February 24, 2017 August 31, 2017 pCODR 10097
Lynparza Olaparib Notification to Implement Issued April 1, 2016 September 29, 2016 pCODR 10081
Keytruda Pembrolizumab Notification to Implement Issued December 12, 2016 August 23, 2017 pCODR 10101
Avastin Bevacizumab Withdrawn December 16, 2016 pCODR 10100
Keytruda Pembrolizumab Notification to Implement Issued April 21, 2016 November 3, 2016 pCODR 10077
Rituxan Rituximab Notification to Implement Issued February 13, 2017 August 31, 2017 pCODR 10102
Onivyde Irinotecan Liposome Notification to Implement Issued April 27, 2017 January 5, 2018 pCODR 10107
Venclexta Venetoclax Notification to Implement Issued July 10, 2017 March 2, 2018 pCODR 10105
Faslodex Fulvestrant Notification to Implement Issued July 17, 2017 February 1, 2018 pCODR 10110
Adcetris Brentuximab Vedotin Notification to Implement Issued August 10, 2017 February 21, 2018 pCODR 10116
TBD Cabozantinib Withdrawn October 6, 2017 pCODR 10123
Mvasi Bevacizumab Final Biosimilar Dossier Issued October 3, 2018 pCODR 10158
Xtandi Enzalutamide Notification to Implement Issued September 24, 2018 March 26, 2019 pCODR 10149
Beleodaq Belinostat Withdrawn June 29, 2018 pCODR 10139
Tagrisso Osimertinib Notification to Implement Issued May 16, 2018 January 4, 2019 pCODR 10137
Blincyto Blinatumomab Notification to Implement Issued August 31, 2018 April 4, 2019 pCODR 10146
Adcetris (Resubmission) Brentuximab Vedotin Notification to Implement Issued August 27, 2018 March 7, 2019 pCODR 10145
Cabometyx Cabozantinib Notification to Implement Issued September 17, 2018 February 20, 2019 pCODR 10163
Besponsa Inotuzumab Ozogamicin Notification to Implement Issued November 13, 2017 July 6, 2018 pCODR 10121
Alunbrig Brigatinib Notification to Implement Issued December 5, 2018 August 1, 2019 pCODR 10167
Bavencio Avelumab Under Review September 18, 2020 pCODR 10225